Researchers Map 1.1 Million Ileal Cells, Uncovering Crohn's Disease Immune and Epithelial Signatures
Updated
Updated · Nature.com · Jun 15
Researchers Map 1.1 Million Ileal Cells, Uncovering Crohn's Disease Immune and Epithelial Signatures
2 articles · Updated · Nature.com · Jun 15
Summary
A 343-person single-cell atlas of terminal ileum biopsies—111 Crohn’s patients and 232 healthy controls—identified disease-linked epithelial and immune programs in more than 1.1 million cells.
The strongest epithelial signal was interferon-driven MHC-I upregulation across the crypt-villus axis, a response that persisted in progenitor cells even after visible inflammation had resolved.
ITGA4-positive macrophages emerged as key inflammatory drivers, expanding to 16% of myeloid cells in inflamed Crohn’s tissue from 10% in health and showing enriched JAK-STAT, IL-6, IL-12 and IL-23 signaling.
Genetic heritability analyses tied Crohn’s risk most strongly to inflammatory monocytes, macrophages and several T-cell populations, pointing to both recruited and resident immune cells in disease causation.
The IBDverse resource also highlighted a reproducibility challenge: fewer than 50% of differentially expressed genes replicated between discovery and validation cohorts, underscoring the need for larger single-cell studies.
Researchers have linked specific genes to rogue immune cells in Crohn's. Does this unlock truly personalized cures?
Can the newly discovered molecular 'scar' in gut cells be erased to prevent Crohn's disease from returning?
Mapping Crohn’s Disease at Single-Cell Resolution: Insights from the IBDverse Study of 343 Patients
Overview
In June 2026, a major new study marked a breakthrough in Crohn's disease research by providing an unprecedented look at the disease at the cellular level. Researchers analyzed terminal ileal biopsies from 343 individuals, including both healthy controls and Crohn's disease patients, revealing detailed cellular and molecular insights. This comprehensive investigation led to the creation of IBDverse, the largest single-cell RNA sequencing resource for Crohn's disease. The study fundamentally advanced our understanding by mapping the disease with high precision, paving the way for more targeted therapies and a deeper knowledge of Crohn's disease biology.